China Universal Asset Management Co., Ltd. Avidity Biosciences, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $1.03 Billion
- Q4 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 25,298 shares of RNA stock, worth $883,406. This represents 0.07% of its overall portfolio holdings.
Number of Shares
25,298
Previous 22,526
12.31%
Holding current value
$883,406
Previous $1.03 Million
28.92%
% of portfolio
0.07%
Previous 0.12%
Shares
15 transactions
Others Institutions Holding RNA
# of Institutions
251Shares Held
107MCall Options Held
224KPut Options Held
161K-
Price T Rowe Associates Inc Baltimore, MD10.6MShares$371 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.23MShares$322 Million0.01% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$301 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY8.13MShares$284 Million5.95% of portfolio
-
Wellington Management Group LLP Boston, MA7.03MShares$246 Million0.06% of portfolio
About Avidity Biosciences, Inc.
- Ticker RNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,127,000
- Market Cap $1.82B
- Description
- Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...